SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (2381)7/2/1997 11:00:00 PM
From: Frostman   of 3991
 
Footwork done by Richard Singer regarding actual sales and inventory is solid stuff. My findings at the pharmacy were consistant with the "Singer Study": strong demand, limited supplies, notable refill activity. It would be interesting if folks in other parts of the country could call their pharmacy and visit about Muse.

Tunica, perhaps this has been covered, but do we know how many shifts Vivus is currently running? Can they increase production...now? If they could, would they not have done so already as an investment in sales and important "first impressions" with docs, pharmacies, and patients. "they are out of the stuff" is real bad advertising IMHO.

Good luck all, great thread.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News